Capricor Therapeutics (CAPR) Long-Term Debt Issuances (2016 - 2018)
Capricor Therapeutics (CAPR) has 7 years of Long-Term Debt Issuances data on record, last reported at -$139140.0 in Q2 2018.
- For Q2 2018, Long-Term Debt Issuances fell 155.66% year-over-year to -$139140.0; the TTM value through Sep 2019 reached -$139140.0, down 155.66%, while the annual FY2020 figure was $318160.0, N/A changed from the prior year.
- Long-Term Debt Issuances reached -$139140.0 in Q2 2018 per CAPR's latest filing, down from $139140.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $3.9 million in Q1 2014 and bottomed at -$139140.0 in Q2 2018.
- Average Long-Term Debt Issuances over 4 years is $880840.3, with a median of $250000.0 recorded in 2017.
- Peak YoY movement for Long-Term Debt Issuances: skyrocketed 357.86% in 2014, then tumbled 155.66% in 2018.
- A 4-year view of Long-Term Debt Issuances shows it stood at -$6667.0 in 2014, then surged by 26348.69% to $1.8 million in 2016, then tumbled by 85.71% to $250000.0 in 2017, then crashed by 155.66% to -$139140.0 in 2018.
- Per Business Quant database, its latest 3 readings for Long-Term Debt Issuances were -$139140.0 in Q2 2018, $139140.0 in Q1 2018, and $250000.0 in Q4 2017.